| Primary |
| Hormone Replacement Therapy |
25.0% |
| Endometriosis |
10.0% |
| Hypertension |
10.0% |
| Menopause |
10.0% |
| Atrophic Vulvovaginitis |
5.0% |
| Blood Cholesterol Abnormal |
5.0% |
| Blood Cholesterol Increased |
5.0% |
| Blood Pressure High |
5.0% |
| High Cholesterol |
5.0% |
| Neuralgia |
5.0% |
| Smoking Cessation Therapy |
5.0% |
| Thyroid Disorder |
5.0% |
| Urinary Incontinence |
5.0% |
|
| Drug Ineffective |
16.7% |
| Alopecia |
5.6% |
| Blood Pressure Inadequately Controlled |
5.6% |
| Discomfort |
5.6% |
| Disturbance In Attention |
5.6% |
| Drug Effect Decreased |
5.6% |
| Drug Effect Incomplete |
5.6% |
| Inappropriate Schedule Of Drug Administration |
5.6% |
| Intentional Drug Misuse |
5.6% |
| Menorrhagia |
5.6% |
| Product Quality Issue |
5.6% |
| Pruritus |
5.6% |
| Transient Ischaemic Attack |
5.6% |
| Uterine Neoplasm |
5.6% |
| Vision Blurred |
5.6% |
| Weight Increased |
5.6% |
|
| Secondary |
| Hormone Replacement Therapy |
40.6% |
| Product Used For Unknown Indication |
24.8% |
| Menopausal Symptoms |
8.7% |
| Menopause |
5.3% |
| Drug Use For Unknown Indication |
4.7% |
| Hypothyroidism |
2.5% |
| Hypertension |
2.1% |
| Vulvovaginal Dryness |
1.3% |
| Anxiety |
1.1% |
| Depression |
1.1% |
| Thyroid Disorder |
1.1% |
| Bladder Disorder |
0.8% |
| Diabetes Mellitus |
0.8% |
| Menopausal Depression |
0.8% |
| Prevention Of Endometrial Hyperplasia |
0.8% |
| Respiratory Tract Infection |
0.8% |
| Blood Pressure |
0.6% |
| Hirsutism |
0.6% |
| Night Sweats |
0.6% |
| Smoking Cessation Therapy |
0.6% |
|
| Breast Cancer Female |
29.8% |
| Breast Cancer |
27.4% |
| Vascular Calcification |
6.0% |
| Liver Disorder |
3.6% |
| Aspiration |
2.4% |
| Breast Cancer Metastatic |
2.4% |
| Breast Cancer Recurrent |
2.4% |
| Endometrial Cancer Stage I |
2.4% |
| Malaise |
2.4% |
| Myocardial Infarction |
2.4% |
| Neuroleptic Malignant Syndrome |
2.4% |
| Oedema Peripheral |
2.4% |
| Rash |
2.4% |
| Surgery |
2.4% |
| Weight Decreased |
2.4% |
| Wrong Technique In Drug Usage Process |
2.4% |
| Activities Of Daily Living Impaired |
1.2% |
| Breast Tenderness |
1.2% |
| Catecholamines Urine Increased |
1.2% |
| Cervicobrachial Syndrome |
1.2% |
|
| Concomitant |
| Drug Use For Unknown Indication |
54.2% |
| Rheumatoid Arthritis |
11.2% |
| Product Used For Unknown Indication |
5.4% |
| Hypertension |
4.0% |
| Pain |
3.5% |
| Hormone Replacement Therapy |
3.3% |
| Insomnia |
2.6% |
| Vitamin Supplementation |
2.0% |
| Blood Cholesterol Increased |
1.7% |
| Depression |
1.6% |
| Hypothyroidism |
1.6% |
| Multiple Myeloma |
1.4% |
| Crohn's Disease |
1.4% |
| Gastrooesophageal Reflux Disease |
1.2% |
| Blood Pressure |
1.2% |
| Hysterectomy |
1.0% |
| Arthritis |
0.7% |
| Psoriatic Arthropathy |
0.7% |
| Blood Cholesterol |
0.7% |
| Mineral Supplementation |
0.7% |
|
| Dysgeusia |
10.1% |
| Insomnia |
10.1% |
| Incorrect Dose Administered |
8.0% |
| Transient Ischaemic Attack |
6.9% |
| Weight Increased |
6.9% |
| Accidental Exposure |
5.9% |
| Drug Ineffective |
4.8% |
| Wrong Technique In Drug Usage Process |
4.8% |
| Pruritus |
4.3% |
| Skin Ulcer |
4.3% |
| Joint Swelling |
3.7% |
| Middle Insomnia |
3.7% |
| Paraesthesia |
3.7% |
| Vomiting |
3.7% |
| Diarrhoea |
3.2% |
| Flushing |
3.2% |
| Injection Site Extravasation |
3.2% |
| Injection Site Pain |
3.2% |
| Nausea |
3.2% |
| Uterine Leiomyoma |
3.2% |
|
